EAU Guidelines on Penile Cancer: 2014 Update

Oliver W. Hakenberg(University of Rostock), Nick Watkin(St George’s University Hospitals NHS Foundation Trust), Éva Compérat(Vienna General Hospital), Chris Protzel(University of Rostock), Suks Minhas(Imperial College Healthcare NHS Trust), Andrea Necchi(Radboud University Nijmegen)
European Urology
November 1, 2014
10.1016/j.eururo.2014.10.017
Cited by 594

Related Papers

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|3.7k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|2.2k
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618
European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2021 Update on Male Infertility
|European Urology|2021|612